Gout
Conditions
Interventions
Experimental group:Subjects assigned to the experimental group will use a transcutaneous electrical nerve stimulation (TENS) device for 30 minutes once daily.
Control group:Subjects randomized to the control group received sham stimulation using a transcutaneous electrical nerve stimulation (TENS) device for 30 minutes once daily.
Sponsors
Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Subjects met the criteria for gout classification established by the American College of Rheumatology and the European League Against Rheumatism in 2015; 2. Individuals aged 18 to 70 years; 3. Those who voluntarily participate and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Pregnant individuals (urine HCG positive) or those who are lactating. 2. Patients with pacemakers. 3. Recent use of anti-anxiety or antidepressant medications. 4. Patients with impaired consciousness, a history of mental illness, or those currently experiencing mental health issues. 5. Patients with skin sensitivity. 6. Patients with severe earlobe erosion or absence of the ear. 7. Patients who have undergone vagus nerve cutting and/or currently have implanted electrical or nerve stimulation devices. 8. A history of vasovagal syncope, significant cardiac arrhythmias, low blood pressure, or severe heart disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual analogue scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pittsburgh sleep quality index;Hamilton Depression Scale;Number of joint swelling and pain;Patient’s or Subjective Global Assessment Scale;Full blood cell count;CRP C-reactive protein;Erythrocyte sedimentation Rate;Cytokine;Uric acid; | — |
Countries
China
Contacts
Public ContactPan Zhenglun
Department of Rheumatology
Outcome results
None listed